BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7000116)

  • 21. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity of human lymphocytes to teratoma preparations as revealed by the macrophage electrophoretic mobility (MEM) technique.
    Irmscher J; Grossmann H; Kotzsch M; Wagner H; Müller M
    Arch Geschwulstforsch; 1982; 52(5):349-53. PubMed ID: 7149908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte sensitization detected by the macrophage electrophoretic mobility assay in patients with renal cell carcinoma: Theophylline increases the sensitivity of the assay.
    Malkovský M; Bubeník J; Malkovská V; Indrová M; Suhajová E; Jakoubková J; Jíra M
    Arch Geschwulstforsch; 1981; 51(4):364-70. PubMed ID: 7032451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The inhibition of the electrophoretic-mobility-test: an in vitro assay for the estimation of activities in anti-lymphokine and anti-lymphocyte sera (author's transl)].
    Werner H; Friemel H; Holzheidt G
    Allerg Immunol (Leipz); 1982; 28(1):47-51. PubMed ID: 6214173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity.
    Rouveix B; Badenoch-Jones P; Turk JL
    Immunology; 1979 Mar; 36(3):589-94. PubMed ID: 374256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis of cancer using lymphocyte electrophoresis (2)].
    Mori T; Kohsaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1675-82. PubMed ID: 6591858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Method of electrophoretic mobility of macrophages and its use in clinical immunology].
    Field EJ; Shenton VK; Jenssen HL; Keöhler H; Günther JK
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):70-5. PubMed ID: 352059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
    Lewkonia RM; Kerr EJ; Irvine WJ
    Br J Cancer; 1974 Dec; 30(6):532-7. PubMed ID: 4447784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of antilymphokine serum activities by the electrophoretic mobility test.
    Friemel H; Werner H; Holzheidt G; Otz U; de Weck AL
    Acta Biol Med Ger; 1982; 41(11):1079-83. PubMed ID: 7170872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicentric squamous and basal cell carcinoma of breast simulating Paget's disease.
    Peison B
    IMJ Ill Med J; 1967 Nov; 132(5):688-92. PubMed ID: 4383997
    [No Abstract]   [Full Text] [Related]  

  • 33. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignancies.
    Douwes FR; Hoffmann W; Mross K
    Oncology; 1977; 34(2):80-3. PubMed ID: 70771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)].
    Kreienberg R; Schütz G; Melchert F; Lemmel EM
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):709-15. PubMed ID: 383565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of kidney transplant survival by the direct macrophage-inhibition test.
    Schweizer RT; Olson EC; Hosey DA; Bartus SA
    Transplant Proc; 1979 Mar; 11(1):411-4. PubMed ID: 156427
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
    Lampert F; Nitzschke U; Zwergel T
    Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.
    Hesse DG; Cole DJ; Van Epps DE; Williams RC
    J Clin Invest; 1984 Apr; 73(4):1078-85. PubMed ID: 6231310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dependence of erythrocyte electrophoretic mobility of human and rat blood on cell volume in health and pathology].
    Matiushichev VB; Shamratova VG
    Patol Fiziol Eksp Ter; 2006; (4):17-8. PubMed ID: 17300083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Parameters of cellular immunity in subjects with bronchial squamous cell tumors].
    Vietti Ramus G; Tartaglino B; Cesano L; Revello F; Barbalonga A
    Minerva Med; 1983 Apr; 74(16):879-87. PubMed ID: 6601781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.